化学&生物药
在化学&生物药领域，最新融资动态显示：Basilea Pharmaceutica Ltd完成IPO后其他轮次融资，投资方为Biomedical Advanced Research and Development Authority。更多详细融资信息，可通过专题列表查阅。
2026-08-05
癌症和传染病治疗药物开发商
医药研发/制造
化学&生物药
Biomedical Advanced Research and Development Authority;
2026-08-05
小分子疗法研发商
医药研发/制造
化学&生物药
University of Strathclyde;
University of Strathclyde;
BioGeneration Ventures;
BioGeneration Ventures;
Sofinnova Partners;
Epidarex Capital;
Roche Venture Fund;
Scottish National Investment Bank;
2026-08-04
可编程治疗方法开发商
医药研发/制造
化学&生物药
Adage Capital Partners LP;
Adage Capital Partners LP;
5AM Ventures;
5AM Ventures;
维梧资本;
Balyasny Asset;
Janus Henderson Investors;
Coastlands Capital;
2026-08-03
细胞和基因疗法研发商
医药研发/制造
化学&生物药
Caligan Partners;
Caligan Partners;
Eventide Asset Management;
Eventide Asset Management;
八方资本;
Redmile Group;
Spruce Street Capital;
Atlas Venture;
Deep Track Capital;
Foresite Capital;
Janus Henderson Investors;
Logos Capital;
Pivotal bioVenture Partners;
RA Capital;
RTW Investments;
TCGX;
Wellington Management;
Balyasny Asset;
诺和诺德;